Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China; Renal Pathological Center, Institute of Nephrology, Peking University, Beijing, China; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China; Laboratory of Electron Microscopy, Pathological Center, Peking University First Hospital, Beijing, China.
Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China; Renal Pathological Center, Institute of Nephrology, Peking University, Beijing, China; Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China.
Kidney Int. 2022 Jul;102(1):196-206. doi: 10.1016/j.kint.2022.03.027. Epub 2022 May 2.
High-altitude polycythemia (HAPC) is a clinical syndrome that occurs in native inhabitants or long-term residents living at altitude. The kidney is one of the most affected organs. However, the clinical and kidney histopathological profiles of HAPC-related kidney disease have rarely been reported. Here, we report kidney biopsy-based clinicopathological study on this disease. HAPC was defined as excessive erythrocytosis [females, hemoglobin 190 g/L or more; males, 210 g/L or more] in patients living above an altitude of 2500 m for more than ten years. A total of 416 Tibetan patients underwent kidney biopsy between January 1, 2016, and November 31, 2020. Of these patients 17 met the diagnostic criteria for HAPC-related kidney disease. Clinically, these patients had a median urinary protein level of 2.5 g/24-hour (range 1.81-6.85). Twelve patients had hyperuricemia, nine had hypertension, and three had kidney insufficiency. On histopathology, glomerular hypertrophy, glomerular basement membrane thickening, podocyte foot process effacement, segmental glomerulosclerosis and global glomerulosclerosis were the main features. Extraglomerular arterial/arteriolar lesions were common, presenting as intimal fibrosis, hyalinosis and endothelial cell swelling/subintimal edema. Expansion of the arterial/arteriolar medial wall area characterized by smooth muscle cell proliferation was clearly observed, potentially indicating vascular remodeling. Hypoxia-inducible factor 2α was expressed in the kidney tissues of these patients. Thus, the pathological changes of HAPC-related kidney disease encompassed both glomerular and extraglomerular vascular lesions, suggesting a key role of both chronic hypoxia itself and secondary hemodynamic changes in the pathogenesis of this disease.
高原红细胞增多症(HAPC)是一种发生在高原地区原住民或长期居住者中的临床综合征。肾脏是受影响最严重的器官之一。然而,HAPC 相关肾脏疾病的临床和肾脏组织病理学特征很少有报道。在这里,我们报告了一项基于肾脏活检的该病临床病理学研究。HAPC 定义为居住在海拔 2500 米以上地区超过十年的患者出现过度红细胞增多症[女性血红蛋白≥190 g/L;男性血红蛋白≥210 g/L]。2016 年 1 月 1 日至 2020 年 11 月 31 日期间,共有 416 名藏族患者接受了肾脏活检。其中 17 名患者符合 HAPC 相关肾脏疾病的诊断标准。临床上,这些患者的尿蛋白中位数为 2.5 g/24 小时(范围 1.81-6.85)。12 名患者存在高尿酸血症,9 名患者存在高血压,3 名患者存在肾功能不全。组织病理学上,肾小球肥大、肾小球基底膜增厚、足细胞足突消失、节段性肾小球硬化和全球性肾小球硬化是主要特征。肾小球外小动脉/小动脉病变常见,表现为内膜纤维化、玻璃样变和内皮细胞肿胀/内膜下水肿。动脉/小动脉中层壁面积扩张,平滑肌细胞增殖明显,提示血管重塑。这些患者的肾脏组织中表达了缺氧诱导因子 2α。因此,HAPC 相关肾脏疾病的病理变化包括肾小球和肾小球外血管病变,提示慢性缺氧本身和继发性血液动力学变化在该疾病发病机制中起关键作用。